Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Naredi, P. Lindér, S. Holmberg, R. Söderberg, G. Carlsson, B. Gustavsson, L. Jacobsson, L. Hafström (1992)
The influence of hepatic artery ligation and of vasopressin on liver tumour blood flow in ratsJournal of Surgical Oncology, 50
W. Cunliffe, P. Sugarbaker (2005)
early postoperative i ntraperitoneal chemotherapy
J. Gyves, W. Ensminger, P. Stetson, J. Niederhuber, M. Meyer, S. Walker, M. Janis, S. Gilbertson (1984)
Constant intraperitoneal 5‐fluorouracil infusion through a totally implanted systemClinical Pharmacology & Therapeutics, 35
A. Lübbe, R. Herrmann, H. Riess, D. Huhn (1993)
Microcirculatory effects of hyperthermia and 5-fluorouracil in the skin of nude mice.International journal of microcirculation, clinical and experimental, 13 3
L. Hafström, A. Nobin, B. Persson, K. Sundqvist (1980)
Effects of catecholamines on cardiovascular response and blood flow distribution to normal tissue and liver tumors in rats.Cancer research, 40 2
M. Oman, J. Tölli, P. Blind, P. Naredi, L. Hafström (2004)
133Xe clearance estimates the effect of vasopressin on peritoneal blood flow in rats.Hepato-gastroenterology, 51 58
T. Iwao, A. Toyonaga, K. Oho, H. Shigemori, T. Sakai, C. Tayama, Hideo Masumoto, Masahiro Sato, K. Tanikawa (1996)
Effect of vasopressin on esophageal varices blood flow in patients with cirrhosis: comparisons with the effects on portal vein and superior mesenteric artery blood flow.Journal of hepatology, 25 4
D. Dietz, S. Casillas, S. Jones, J. Milsom (1998)
Vasopressin selectively increases 5-fluorouracil uptake by colorectal liver metastases following hepatic artery bolus infusion.The Journal of surgical research, 77 2
P. Lindnér, D. Heath, D. Shalinsky, S. Howell, P. Naredi, L. Hafström (1993)
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposide.Surgical oncology, 2 2
R. Ottow, E. Steller, P. Sugarbaker, R. Wesley, S. Rosenberg (1987)
Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine models.Cellular immunology, 104 2
P. Lindnér, D. Heath, S. Howell, P. Naredi, L. Hafström (1996)
Vasopressin modulation of peritoneal, lymphatic, and plasma drug exposure following intraperitoneal administration.Clinical cancer research : an official journal of the American Association for Cancer Research, 2 2
A. Hugander, M. Bolmsjö, L. Hafström, B. Persson (1983)
Liver blood flow studies during local hyperthermia. An experimental study in rats.Clinical oncology, 9 4
J. Balthasar, H. Fung (1996)
Pharmacokinetic and pharmacodynamic optimization of intraperitoneal chemotherapy.Life sciences, 58 7
A. Cardozo, A. Gupta, M. Koppe, S. Meijer, P. Leeuwen, R. Beelen, R. Bleichrodt (2001)
Metastatic pattern of CC531 colon carcinoma cells in the abdominal cavity: an experimental model of peritoneal carcinomatosis in rats.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 27 4
P. Sugarbaker, D. Landy, R. Pascal (1990)
Intraperitoneal chemotherapy for peritoneal carcinomatosis from colonic or appendiceal cystadenocarcinoma: rationale and results of treatment.Progress in clinical and biological research, 354B
J. Speyer, P. Sugarbaker, J. Collins, R. Dedrick, R. Klecker, C. Myers (1981)
Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.Cancer research, 41 5
C. Atkins (2003)
Intraperitoneal chemotherapy for stage III ovarian cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 5
M. El-Malt, W. Ceelen, C. Broecke, C. Cuvelier, S. Belle, W. Neve, B. Hemptinne, P. Pattyn (2001)
Healing of experimental colonic anastomoses: Effects of combined preoperative high‐dose radiotherapy and intraperitoneal 5‐fluorouracilInternational Journal of Cancer, 96
M. Oman, P. Blind, P. Naredi, B. Gustavsson, L. Hafström (2001)
Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IV.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 27 5
G. Steele, H. Sjögren (1974)
Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas.Cancer research, 34 8
I. Kjartansson (1976)
Tumour circulation. An experimental study in the rat with a comparison of different methods for estimation of tumour blood flow.Acta chirurgica Scandinavica. Supplementum, 471
M. Markman (2003)
Intraperitoneal antineoplastic drug delivery: rationale and results.The Lancet. Oncology, 4 5
K. Janunger, L. Hafström, P. Nygren, B. Glimelius (2001)
A systematic overview of chemotherapy effects in gastric cancer.Acta oncologica, 40 2-3
Intravenous vasopressin at 0.07 IU/min/kg decreased peritoneal blood flow as measured indirectly with the 133 Xe-clearance method. Intraperitoneal 5-FU abrogated the reduction in peritoneal blood flow with intravenous vasopressin the first day after treatment. In contrast, the presence of peritoneal carcinomatosis did not influence peritoneal blood flow, nor the effect of vasopressin
Cancer Chemotherapy and Pharmacology – Springer Journals
Published: Sep 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.